Tucker T. Marra M. Friedman J.M.

Massively parallel sequencing: the next big thing in genetic medicine.

Am J Hum Genet. 85: 142-154Samani N.J. Tomaszewski M. Schunkert H.

The personal genome--the future of personalised medicine?.

Lancet. 375: 1497-1498

Between hype and hope: whole-genome sequencing in clinical medicine.

Per Med. 9: 243-246Talbert M.L. Dunn S.T. Hunt J. Hillyard D.R. Mirza I. Nowak J.A. Van Deerlin V. Vnencak-Jones C.L.

Competency-based education for the molecular genetic pathology fellow: a report of the association for molecular pathology training and education committee.

J Mol Diagn. 11: 497-507Hellmann M.D. Ciuleanu T.E. Pluzanski A. Lee J.S. Otterson G.A. Audigier-Valette C. Minenza E. Linardou H. Burgers S. Salman P. Borghaei H. Ramalingam S.S. Brahmer J. Reck M. O'Byrne K.J. Geese W.J. Green G. Chang H. Szustakowski J. Bhagavatheeswaran P. Healey D. Fu Y. Nathan F. Paz-Ares L.

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.

N Engl J Med. 378: 2093-2104Hellmann M.D. Callahan M.K. Awad M.M. Calvo E. Ascierto P.A. Atmaca A. Rizvi N.A. Hirsch F.R. Selvaggi G. Szustakowski J.D. Sasson A. Golhar R. Vitazka P. Chang H. Geese W.J. Antonia S.J.

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.

Cancer Cell. 33: 853-861 e854Pai S.G. Carneiro B.A. Chae Y.K. Costa R.L. Kalyan A. Shah H.A. Helenowski I. Rademaker A.W. Mahalingam D. Giles F.J.

Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer.

J Gastrointest Oncol. 8: 858-866Vanderwalde A. Spetzler D. Xiao N. Gatalica Z. Marshall J.

Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients.

Cancer Med. 7: 746-756Hempelmann J.A. Lockwood C.M. Konnick E.Q. Schweizer M.T. Antonarakis E.S. Lotan T.L. Montgomery B. Nelson P.S. Klemfuss N. Salipante S.J. Pritchard C.C.

Microsatellite instability in prostate cancer by PCR or next-generation sequencing.

J Immunother Cancer. 6: 29Telli M.L. Timms K.M. Reid J. Hennessy B. Mills G.B. Jensen K.C. Szallasi Z. Barry W.T. Winer E.P. Tung N.M. Isakoff S.J. Ryan P.D. Greene-Colozzi A. Gutin A. Sangale Z. Iliev D. Neff C. Abkevich V. Jones J.T. Lanchbury J.S. Hartman A.R. Garber J.E. Ford J.M. Silver D.P. Richardson A.L.

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

Clin Cancer Res. 22: 3764-3773Telli M.L. Hellyer J. Audeh W. Jensen K.C. Bose S. Timms K.M. Gutin A. Abkevich V. Peterson R.N. Neff C. Hughes E. Sangale Z. Jones J. Hartman A.R. Chang P.J. Vinayak S. Wenstrup R. Ford J.M.

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.

Breast Cancer Res Treat. 168: 625-630Ehrenberg P.K. Geretz A. Baldwin K.M. Apps R. Polonis V.R. Robb M.L. Kim J.H. Michael N.L. Thomas R.

High-throughput multiplex HLA genotyping by next-generation sequencing using multi-locus individual tagging.

BMC Genomics. 15: 864Smith A.G. Pyo C.W. Nelson W. Gow E. Wang R. Shen S. Sprague M. Pereira S.E. Geraghty D.E. Hansen J.A.

Next generation sequencing to determine HLA class II genotypes in a cohort of hematopoietic cell transplant patients and donors.

Hum Immunol. 75: 1040-1046Weimer E.T. Montgomery M. Petraroia R. Crawford J. Schmitz J.L.

Performance Characteristics and Validation of Next-Generation Sequencing for Human Leucocyte Antigen Typing.

J Mol Diagn. 18: 668-675Gandhi M.J. Ferriola D. Huang Y. Duke J.L. Monos D.

Targeted Next-Generation Sequencing for Human Leukocyte Antigen Typing in a Clinical Laboratory: Metrics of Relevance and Considerations for Its Successful Implementation.

Arch Pathol Lab Med. 141: 806-812Orzinska A. Guz K. Mikula M. Kluska A. Balabas A. Ostrowski J. Uhrynowska M. Kopec I. Debska M. Luterek K. Brojer E.

Prediction of fetal blood group and platelet antigens from maternal plasma using next-generation sequencing.

Transfusion. 59: 1102-1107Orzinska A. Guz K. Mikula M. Kulecka M. Kluska A. Balabas A. Pelc-Klopotowska M. Ostrowski J. Brojer E.

A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors.

Blood Transfus. 16: 285-292Sufficool K.E. Lockwood C.M. Abel H.J. Hagemann I.S. Schumacher J.A. Kelley T.W. Duncavage E.J.

T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.

J Am Acad Dermatol. 73: 228-236 e222Arcila M.E. Yu W. Syed M. Kim H. Maciag L. Yao J. Ho C. Petrova K. Moung C. Salazar P. Rijo I. Baldi T. Zehir A. Landgren O. Park J. Roshal M. Dogan A. Nafa K.

Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms.

J Mol Diagn. 21: 330-342Wu D. Emerson R.O. Sherwood A. Loh M.L. Angiolillo A. Howie B. Vogt J. Rieder M. Kirsch I. Carlson C. Williamson D. Wood B.L. Robins H.

Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH.

Clin Cancer Res. 20: 4540-4548Wu D. Sherwood A. Fromm J.R. Winter S.S. Dunsmore K.P. Loh M.L. Greisman H.A. Sabath D.E. Wood B.L. Robins H.

High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia.

Sci Transl Med. 4: 134ra163Wood B. Wu D. Crossley B. Dai Y. Williamson D. Gawad C. Borowitz M.J. Devidas M. Maloney K.W. Larsen E. Winick N. Raetz E. Carroll W.L. Hunger S.P. Loh M.L. Robins H. Kirsch I.

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.

Blood. 131: 1350-1359Schumacher J.A. Duncavage E.J. Mosbruger T.L. Szankasi P.M. Kelley T.W.

A comparison of deep sequencing of TCRG rearrangements vs traditional capillary electrophoresis for assessment of clonality in T-Cell lymphoproliferative disorders.

Am J Clin Pathol. 141: 348-359Gawad C. Pepin F. Carlton V.E. Klinger M. Logan A.C. Miklos D.B. Faham M. Dahl G. Lacayo N.

Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia.

Blood. 120: 4407-4417Perrot A. Lauwers-Cances V. Corre J. Robillard N. Hulin C. Chretien M.L. Dejoie T. Maheo S. Stoppa A.M. Pegourie B. Karlin L. Garderet L. Arnulf B. Doyen C. Meuleman N. Royer B. Eveillard J.R. Benboubker L. Dib M. Decaux O. Jaccard A. Belhadj K. Brechignac S. Kolb B. Fohrer C. Mohty M. Macro M. Richardson P.G. Carlton V. Moorhead M. Willis T. Faham M. Anderson K.C. Harousseau J.L. Leleu X. Facon T. Moreau P. Attal M. Avet-Loiseau H. Munshi N.

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Blood. 132: 2456-2464Wu D. Waalkes A. Penewit K. Salipante S.J.

Ultrasensitive Detection of Chimerism by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing of Copy Number Deletion Polymorphisms.

Clin Chem. 64: 938-949Aloisio M. Licastro D. Caenazzo L. Torboli V. D'Eustacchio A. Severini G.M. Athanasakis E.

A technical application of quantitative next generation sequencing for chimerism evaluation.

Mol Med Rep. 14: 2967-2974Gu W. Miller S. Chiu C.Y.

Clinical Metagenomic Next-Generation Sequencing for Pathogen Detection.

Annu Rev Pathol. 14: 319-338Simner P.J. Miller S. Carroll K.C.

Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious Diseases.

Clin Infect Dis. 66: 778-788Blauwkamp T.A. Thair S. Rosen M.J. Blair L. Lindner M.S. Vilfan I.D. Kawli T. Christians F.C. Venkatasubrahmanyam S. Wall G.D. Cheung A. Rogers Z.N. Meshulam-Simon G. Huijse L. Balakrishnan S. Quinn J.V. Hollemon D. Hong D.K. Vaughn M.L. Kertesz M. Bercovici S. Wilber J.C. Yang S.

Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease.

Nat Microbiol. 4: 663-674Cummings L.A. Kurosawa K. Hoogestraat D.R. SenGupta D.J. Candra F. Doyle M. Thielges S. Land T.A. Rosenthal C.A. Hoffman N.G. Salipante S.J. Cookson B.T.

Clinical Next Generation Sequencing Outperforms Standard Microbiological Culture for Characterizing Polymicrobial Samples.

Clin Chem. 62: 1465-1473

Aref-Eshghi E, Kerkhof J, Pedro VP, Groupe DIF, Barat-Houari M, Ruiz-Pallares N, Andrau JC, Lacombe D, Van-Gils J, Fergelot P, Dubourg C, Cormier-Daire V, Rondeau S, Lecoquierre F, Saugier-Veber P, Nicolas G, Lesca G, Chatron N, Sanlaville D, Vitobello A, Faivre L, Thauvin-Robinet C, Laumonnier F, Raynaud M, Alders M, Mannens M, Henneman P, Hennekam RC, Velasco G, Francastel C, Ulveling D, Ciolfi A, Pizzi S, Tartaglia M, Heide S, Heron D, Mignot C, Keren B, Whalen S, Afenjar A, Bienvenu T, Campeau PM, Rousseau J, Levy MA, Brick L, Kozenko M, Balci TB, Siu VM, Stuart A, Kadour M, Masters J, Takano K, Kleefstra T, de Leeuw N, Field M, Shaw M, Gecz J, Ainsworth PJ, Lin H, Rodenhiser DI, Friez MJ, Tedder M, Lee JA, DuPont BR, Stevenson RE, Skinner SA, Schwartz CE, Genevieve D, Sadikovic B: Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders. Am J Hum Genet 2020, 106:356-370.

Burmester J.K. Sedova M. Shapero M.H. Mansfield E.

DMET microarray technology for pharmacogenomics-based personalized medicine.

Methods Mol Biol. 632: 99-124Miller D.T. Adam M.P. Aradhya S. Biesecker L.G. Brothman A.R. Carter N.P. Church D.M. Crolla J.A. Eichler E.E. Epstein C.J. Faucett W.A. Feuk L. Friedman J.M. Hamosh A. Jackson L. Kaminsky E.B. Kok K. Krantz I.D. Kuhn R.M. Lee C. Ostell J.M. Rosenberg C. Scherer S.W. Spinner N.B. Stavropoulos D.J. Tepperberg J.H. Thorland E.C. Vermeesch J.R. Waggoner D.J. Watson M.S. Martin C.L. Ledbetter D.H.

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Am J Hum Genet. 86: 749-764South S.T. Lee C. Lamb A.N. Higgins A.W. Kearney H.M.

Working Group for the American College of Medical G, Genomics Laboratory Quality Assurance C: ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013.

Genet Med. 15: 901-909Spencer D.H. Sehn J.K. Abel H.J. Watson M.A. Pfeifer J.D. Duncavage E.J.

Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens.

J Mol Diagn. 15: 623-633Bass B.P. Engel K.B. Greytak S.R. Moore H.M.

A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen?.

Arch Pathol Lab Med. 138: 1520-1530Srinivasan M. Sedmak D. Jewell S.

Effect of fixatives and tissue processing on the content and integrity of nucleic acids.

Am J Pathol. 161: 1961-1971Sussman R. Rosenbaum J.N.

Development and Validation of Molecular Assays for Limited Tissue Samples.

Acta Cytol. 64: 147-154McNulty S.N. Parikh B.A. Duncavage E.J. Heusel J.W. Pfeifer J.D.

Optimization of Population Frequency Cutoffs for Filtering Common Germline Polymorphisms from Tumor-Only Next-Generation Sequencing Data.

J Mol Diagn. 21: 903-912Cheng D.T. Mitchell T.N. Zehir A. Shah R.H. Benayed R. Syed A. Chandramohan R. Liu Z.Y. Won H.H. Scott S.N. Brannon A.R. O'Reilly C. Sadowska J. Casanova J. Yannes A. Hechtman J.F. Yao J. Song W. Ross D.S. Oultache A. Dogan S. Borsu L. Hameed M. Nafa K. Arcila M.E. Ladanyi M. Berger M.F.

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

J Mol Diagn. 17: 251-264Sholl L.M. Do K. Shivdasani P. Cerami E. Dubuc A.M. Kuo F.C. Garcia E.P. Jia Y. Davineni P. Abo R.P. Pugh T.J. van Hummelen P. Thorner A.R. Ducar M. Berger A.H. Nishino M. Janeway K.A. Church A. Harris M. Ritterhouse L.L. Campbell J.D. Rojas-Rudilla V. Ligon A.H. Ramkissoon S. Cleary J.M. Matulonis U. Oxnard G.R. Chao R. Tassell V. Christensen J. Hahn W.C. Kantoff P.W. Kwiatkowski D.J. Johnson B.E. Meyerson M. Garraway L.A. Shapiro G.I. Rollins B.J. Lindeman N.I. MacConaill L.E.

Institutional implementation of clinical tumor profiling on an unselected cancer population.

JCI Insight. 1e87062Cheng D.T. Prasad M. Chekaluk Y. Benayed R. Sadowska J. Zehir A. Syed A. Wang Y.E. Somar J. Li Y. Yelskaya Z. Wong D. Robson M.E. Offit K. Berger M.F. Nafa K. Ladanyi M. Zhang L.

Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.

BMC Med Genomics. 10: 33

Next-generation sequencing platforms.

Annu Rev Anal Chem (Palo Alto Calif). 6: 287-303Logsdon G.A. Vollger M.R. Eichler E.E.

Long-read human genome sequencing and its applications.

Nat Rev Genet. 21: 597-614McCombie W.R. McPherson J.D. Mardis E.R.

Next-Generation Sequencing Technologies.

Cold Spring Harb Perspect Med. 9van Dijk E.L. Auger H. Jaszczyszyn Y. Thermes C.

Ten years of next-generation sequencing technology.

Trends Genet. 30: 418-426SoRelle J.A. Wachsmann M. Cantarel B.L.

Assembling and Validating Bioinformatic Pipelines for Next-Generation Sequencing Clinical Assays.

Arch Pathol Lab Med. 144: 1118-1130Roy S. Coldren C. Karunamurthy A. Kip N.S. Klee E.W. Lincoln S.E. Leon A. Pullambhatla M. Temple-Smolkin R.L. Voelkerding K.V. Wang C. Carter A.B.

Standards and Guidelines for Validating Next-Generation Sequencing Bioinformatics Pipelines: A Joint Recommendation of the Association for Molecular Pathology and the College of American Pathologists.

J Mol Diagn. 20: 4-27Lubin I.M. Aziz N. Babb L.J. Ballinger D. Bisht H. Church D.M. Cordes S. Eilbeck K. Hyland F. Kalman L. Landrum M. Lockhart E.R. Maglott D. Marth G. Pfeifer J.D. Rehm H.L. Roy S. Tezak Z. Truty R. Ullman-Cullere M. Voelkerding K.V. Worthey E.A. Zaranek A.W. Zook J.M.

Principles and Recommendations for Standardizing the Use of the Next-Generation Sequencing Variant File in Clinical Settings.

J Mol Diagn. 19: 417-426Gargis A.S. Kalman L. Bick D.P. da Silva C. Dimmock D.P. Funke B.H. Gowrisankar S. Hegde M.R. Kulkarni S. Mason C.E. Nagarajan R. Voelkerding K.V. Worthey E.A. Aziz N. Barnes J. Bennett S.F. Bisht H. Church D.M. Dimitrova Z. Gargis S.R. Hafez N. Hambuch T. Hyland F.C. Luna R.A. MacCannell D. Mann T. McCluskey M.R. McDaniel T.K. Ganova-Raeva L.M. Rehm H.L. Reid J. Campo D.S. Resnick R.B. Ridge P.G. Salit M.L. Skums P. Wong L.J. Zehnbauer B.A. Zook J.M. Lubin I.M.

Good laboratory practice for clinical next-generation sequencing informatics pipelines.

Nat Biotechnol. 33: 689-693Aziz N. Zhao Q. Bry L. Driscoll D.K. Funke B. Gibson J.S. Grody W.W. Hegde M.R. Hoeltge G.A. Leonard D.G. Merker J.D. Nagarajan R. Palicki L.A. Robetorye R.S. Schrijver I. Weck K.E. Voelkerding K.V.

College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.

Arch Pathol Lab Med. 139: 481-493Schrijver I. Aziz N. Farkas D.H. Furtado M. Gonzalez A.F. Greiner T.C. Grody W.W. Hambuch T. Kalman L. Kant J.A. Klein R.D. Leonard D.G. Lubin I.M. Mao R. Nagan N. Pratt V.M. Sobel M.E. Voelkerding K.V. Gibson J.S.

Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology.

J Mol Diagn. 14: 525-540Coonrod E.M. Durtschi J.D. Margraf R.L. Voelkerding K.V.

Developing genome and exome sequencing for candidate gene identification in inherited disorders: an integrated technical and bioinformatics approach.

Arch Pathol Lab Med. 137: 415-433Richards S. Aziz N. Bale S. Bick D. Das S. Gastier-Foster J. Grody W.W. Hegde M. Lyon E. Spector E. Voelkerding K. Rehm H.L. Committee A.L.Q.A.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Genet Med. 17: 405-424Li M.M. Datto M. Duncavage E.J. Kulkarni S. Lindeman N.I. Roy S. Tsimberidou A.M. Vnencak-Jones C.L. Wolff D.J. Younes A. Nikiforova M.N.

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.

J Mol Diagn. 19: 4-23Clarke L. Fairley S. Zheng-Bradley X. Streeter I. Perry E. Lowy E. Tasse A.M. Flicek P.

The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data.

Nucleic Acids Res. 45: D854-D859Genomes Project C. Auton A. Brooks L.D. Durbin R.M. Garrison E.P. Kang H.M. Korbel J.O. Marchini J.L. McCarthy S. McVean G.A. Abecasis G.R.

A global reference for human genetic variation.

Nature. 526: 68-74Sherry S.T. Ward M.H. Kholodov M. Baker J. Phan L. Smigielski E.M. Sirotkin K.

dbSNP: the NCBI database of genetic variation.

Nucleic Acids Res. 29: 308-311Lappalainen I. Lopez J. Skipper L. Hefferon T. Spalding J.D. Garner J. Chen C. Maguire M. Corbett M. Zhou G. Paschall J. Ananiev V. Flicek P. Church D.M.

DbVar and DGVa: public archives for genomic structural variation.

Nucleic Acids Res. 41: D936-941

Exome Variant Server. 2019.

Karczewski K.J. Francioli L.C. Tiao G. Cummings B.B. Alföldi J. Wang Q. Collins R.L. Laricchia K.M. Ganna A. Birnbaum D.P. Gauthier L.D. Brand H. Solomonson M. Watts N.A. Rhodes D. Singer-Berk M. England E.M. Seaby E.G. Kosmicki J.A. Walters R.K. Tashman K. Farjoun Y. Banks E. Poterba T. Wang A. Seed C. Whiffin N. Chong J.X. Samocha K.E. Pierce-Hoffman E. Zappala Z. O’Donnell-Luria A.H. Minikel E.V. Weisburd B. Lek M. Ware J.S. Vittal C. Armean I.M. Bergelson L. Cibulskis K. Connolly K.M. Covarrubias M. Donnelly S. Ferriera S. Gabriel S. Gentry J. Gupta N. Jeandet T. Kaplan D. Llanwarne C. Munshi R. Novod S. Petrillo N. Roazen D. Ruano-Rubio V. Saltzman A. Schleicher M. Soto J. Tibbetts K. Tolonen C. Wade G. Talkowski M.E. Neale B.M. Daly M.J. MacArthur D.G.

Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes.

bioRxiv. : 531210Glusman G. Caballero J. Mauldin D.E. Hood L. Roach J.C.

Kaviar: an accessible system for testing SNV novelty.

Bioinformatics. 27: 3216-3217Landrum M.J. Lee J.M. Benson M. Brown G.R. Chao C. Chitipiralla S. Gu B. Hart J. Hoffman D. Jang W. Karapetyan K. Katz K. Liu C. Maddipatla Z. Malheiro A. McDaniel K. Ovetsky M. Riley G. Zhou G. Holmes J.B. Kattman B.L. Maglott D.R.

ClinVar: improving access to variant interpretations and supporting evidence.

Nucleic Acids Res. 46: D1062-D1067Firth H.V. Richards S.M. Bevan A.P. Clayton S. Corpas M. Rajan D. Van Vooren S. Moreau Y. Pettett R.M. Carter N.P.

DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources.

Am J Hum Genet. 84: 524-533

GeneReviews((R)). Edited by Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A. Seattle (WA), 1993.

Stenson P.D. Mort M. Ball E.V. Shaw K. Phillips A. Cooper D.N.

The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine.

Hum Genet. 133: 1-9Fokkema I.F. Taschner P.E. Schaafsma G.C. Celli J. Laros J.F. den Dunnen J.T.

LOVD v.2.0: the next generation in gene variant databases.

Hum Mutat. 32: 557-563